Related Experiment Video
Updated: Jun 21, 2026
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Anti-IgE therapy in allergic asthma
Claudia Rolinck-Werninghaus1, Ulrich Wahn, Eckard Hamelmann
1Department of Paediatric Pneumology and Immunology, Charité, Campus Virchow, University Children's Hospital, Humboldt-University, Augustenburger Platz 1, D-13353 Berlin, Germany.
Current Drug Targets. Inflammation and Allergy
|October 27, 2005
Summary
Targeting immunoglobulin E (IgE) with anti-IgE antibodies offers a novel approach for allergic asthma treatment. This review explores IgE
Area of Science:
- Immunology
- Allergology
- Pharmacology
Background:
- Current asthma treatments are unspecific, targeting late stages of allergic reactions.
- Understanding asthma pathophysiology has advanced, yet effective targeted therapies are limited.
Purpose of the Study:
- To review the role of immunoglobulin E (IgE) in asthma pathology.
- To summarize current data on anti-IgE antibody therapy's action, safety, and efficacy.
- To propose rational future directions for anti-IgE treatment in allergic asthma.
Main Methods:
- Literature review of IgE's role in allergic diseases.
- Analysis of clinical trial data for anti-IgE therapies.
- Synthesis of current evidence on anti-IgE mechanism of action and clinical outcomes.
Main Results:
- IgE plays a central role in allergic asthma.
- Anti-IgE antibodies demonstrate potential in managing allergic asthma.
- Current data suggests a favorable safety profile for anti-IgE therapy.
Conclusions:
- Anti-IgE antibody therapy represents a promising targeted approach for allergic asthma.
- Further research is needed to optimize patient selection and treatment strategies.
- Future indications may expand beyond current allergic asthma management.
Related Concept Videos
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...